Literature DB >> 10888701

Antinuclear antibodies: cause of disease or caused by disease?

R J Smeenk.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10888701     DOI： 10.1093/rheumatology/39.6.581

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Antibody transfection into neurons as a tool to study disease pathogenesis.

Authors:  Joshua N Douglas; Lidia A Gardner; Sangmin Lee; Yoojin Shin; Chassidy J Groover; Michael C Levin
Journal:  J Vis Exp       Date:  2012-09-26       Impact factor: 1.355

2.  Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Bruce K Tan; Quan-Zhen Li; Lydia Suh; Atsushi Kato; David B Conley; Rakesh K Chandra; Jinchun Zhou; James Norton; Roderick Carter; Monique Hinchcliff; Kathleen Harris; Anju Peters; Leslie C Grammer; Robert C Kern; Chandra Mohan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2011-10-13       Impact factor: 10.793

3.  The prevalence of autoantibodies in complex regional pain syndrome type I.

Authors:  Maaike Dirckx; Marco W J Schreurs; Marissa de Mos; Dirk L Stronks; Frank J P M Huygen
Journal:  Mediators Inflamm       Date:  2015-02-08       Impact factor: 4.711

4.  Lack of Clinical Relevance of ANA and ASMA Positivity in Patients with Liver Transplantation without a History of Autoimmune Diseases.

Authors:  Lucienne Pellegrini; Gianpaolo Parrilli; Antonella Santonicola; Luigi Cinquanta; Cesare Caputo; Carolina Ciacci; Fabiana Zingone
Journal:  Biomed Res Int       Date:  2017-02-27       Impact factor: 3.411

5.  Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies.

Authors:  Josip Sremec; Sanja Tomasović; Nada Tomić Sremec; Alan Šućur; Jelena Košćak Lukač; Koraljka Bačić Baronica; Danka Grčević; Nataša Kovačić
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

6.  Statin use and markers of immunity in the Doetinchem cohort study.

Authors:  Hilda J I De Jong; Jan G M C Damoiseaux; Rob J Vandebriel; Patrick C Souverein; Eric R Gremmer; Mia Wolfs; Olaf H Klungel; Henk Van Loveren; Jan Willem Cohen Tervaert; W M Monique Verschuren
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

7.  Antinuclear antibodies in rosacea patients.

Authors:  Anna Woźniacka; Małgorzata Salamon; Daniel McCauliffe; Anna Sysa-Jędrzejowska
Journal:  Postepy Dermatol Alergol       Date:  2013-02-20       Impact factor: 1.837

8.  Is peripheral paraneoplastic neurological syndrome possible in primary brain tumors?

Authors:  Magdalena Koszewicz; Slawomir Michalak; Malgorzata Bilinska; Slawomir Budrewicz; Mikolaj Zaborowski; Krzysztof Slotwinski; Ryszard Podemski; Maria Ejma
Journal:  Brain Behav       Date:  2016-04-27       Impact factor: 2.708
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.